Insider Transactions in Q4 2022 at Gossamer Bio, Inc. (GOSS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 24
2022
|
Richard Aranda Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,757
-2.26%
|
$57,084
$12.07 P/Share
|
|
Oct 24
2022
|
Laura Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,876
-5.59%
|
$58,512
$12.07 P/Share
|
|
Oct 24
2022
|
Caryn Peterson EVP, Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
4,757
-7.19%
|
$57,084
$12.07 P/Share
|